-
1
-
-
84976512673
-
Pharmacology of alpha-glucosidase inhibition
-
Bischoff H. 1994. Pharmacology of alpha-glucosidase inhibition. Eur J Clin Invest 24: S3-S10.
-
(1994)
Eur J Clin Invest
, vol.24
-
-
Bischoff, H.1
-
2
-
-
0027938631
-
Alpha-glucosidase inhibition in diabetes: Lessons from animal studies
-
Peterson RG. 1994. Alpha-glucosidase inhibition in diabetes: lessons from animal studies. Eur J Clin Invest 24: S11-S18.
-
(1994)
Eur J Clin Invest
, vol.24
-
-
Peterson, R.G.1
-
3
-
-
0022455206
-
Synthesis and alpha-D-glucosidase activity of N-substituted valioamine derivatives as potential oral antidiabetic agents
-
Horii S, Fukase H, Matsuo T, Kameda Y, Asano N, Matsui K. 1986. Synthesis and alpha-D-glucosidase activity of N-substituted valioamine derivatives as potential oral antidiabetic agents. J Med Chem 29: 1038-1046.
-
(1986)
J Med Chem
, vol.29
, pp. 1038-1046
-
-
Horii, S.1
Fukase, H.2
Matsuo, T.3
Kameda, Y.4
Asano, N.5
Matsui, K.6
-
4
-
-
0026558790
-
Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes
-
Matsuo T, Odaka H, Ikeda H. 1992. Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes. Am J Clin Nutr 55: 314S-317S.
-
(1992)
Am J Clin Nutr
, vol.55
-
-
Matsuo, T.1
Odaka, H.2
Ikeda, H.3
-
5
-
-
0033578476
-
Pharmacologic theraphy for type 2 diabetes mellitus
-
DeFronzo RA. 1999. Pharmacologic theraphy for type 2 diabetes mellitus. Ann Intern Med 131: 281-303.
-
(1999)
Ann Intern Med
, vol.131
, pp. 281-303
-
-
DeFronzo, R.A.1
-
6
-
-
0029122656
-
An alpha-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans
-
Goto Y, Yamada K, Ohyama T, Matsuo T, Odaka H, Ikeda H. 1995. An alpha-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Res Clin Pract 28: 81-87.
-
(1995)
Diabetes Res Clin Pract
, vol.28
, pp. 81-87
-
-
Goto, Y.1
Yamada, K.2
Ohyama, T.3
Matsuo, T.4
Odaka, H.5
Ikeda, H.6
-
7
-
-
0017236949
-
Purification and properties of an alpha-amylase inhibitor from wheat
-
O'Donnell MD, McGeeney KF. 1976. Purification and properties of an alpha-amylase inhibitor from wheat. Biochim Biophys Acta 422: 159-169.
-
(1976)
Biochim Biophys Acta
, vol.422
, pp. 159-169
-
-
O'Donnell, M.D.1
McGeeney, K.F.2
-
8
-
-
1942455756
-
Inhibitory effect of 0.19 alpha-amylase inhibitor from wheat kernel on the activity of porcine pancreas alpha-amylase and its thermal stability
-
Oneda H, Lee S, Inouye K. 2004. Inhibitory effect of 0.19 alpha-amylase inhibitor from wheat kernel on the activity of porcine pancreas alpha-amylase and its thermal stability. J Biochem 135: 421-427.
-
(2004)
J Biochem
, vol.135
, pp. 421-427
-
-
Oneda, H.1
Lee, S.2
Inouye, K.3
-
9
-
-
40949146199
-
Chestnut astringent skin extract, an amylase inhibitor, retards carbohydrate absorption in rats and humans
-
Tsujita T, Takaku T, Suzuki T. 2008. Chestnut astringent skin extract, an amylase inhibitor, retards carbohydrate absorption in rats and humans. J Nutr Sci Vitaminol 54: 82-88.
-
(2008)
J Nutr Sci Vitaminol
, vol.54
, pp. 82-88
-
-
Tsujita, T.1
Takaku, T.2
Suzuki, T.3
-
10
-
-
0017913374
-
A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems
-
Kessler M, Acuto O, Storelli C, Murer H, Müler M, Semenza G. 1978. A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. Biochim Biophys Acta 506: 136-154.
-
(1978)
Biochim Biophys Acta
, vol.506
, pp. 136-154
-
-
Kessler, M.1
Acuto, O.2
Storelli, C.3
Murer, H.4
Müler, M.5
Semenza, G.6
-
11
-
-
4444368426
-
Method for assay of intestinal disaccharidases
-
Dahlqvist A. 1964. Method for assay of intestinal disaccharidases. Anal Biochem 7: 18-2 5.
-
(1964)
Anal Biochem
, vol.7
, Issue.18 -2
, pp. 5
-
-
Dahlqvist, A.1
-
12
-
-
33747333106
-
Use of dinitrosalicylic acid reagent for determination of reducing suger
-
Miller GL. 1959. Use of dinitrosalicylic acid reagent for determination of reducing suger. Anal Chem 31: 426-428.
-
(1959)
Anal Chem
, vol.31
, pp. 426-428
-
-
Miller, G.L.1
-
13
-
-
33747125112
-
Antiobesity action of epsilon-polylysine, a potent inhibitor of pancreatic lipase
-
Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J. 2006. Antiobesity action of epsilon-polylysine, a potent inhibitor of pancreatic lipase. J Lipid Res 47: 1852-1858.
-
(2006)
J Lipid Res
, vol.47
, pp. 1852-1858
-
-
Tsujita, T.1
Takaichi, H.2
Takaku, T.3
Aoyama, S.4
Hiraki, J.5
-
14
-
-
33845984333
-
Epidemic obesity and type 2 diabetes in Asia
-
Yoon KH, Lee JH, Kim JW, Cho JH, Ko SH, Zimmet P. Son HY. 2006. Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 1681-1688.
-
(2006)
Lancet
, vol.368
, pp. 1681-1688
-
-
Yoon, K.H.1
Lee, J.H.2
Kim, J.W.3
Cho, J.H.4
Ko, S.H.5
Zimmet, P.6
Son, H.Y.7
-
15
-
-
0035675342
-
Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: The epidemiological evidence
-
Bonora E, Muggeo M. 2001. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44: 2107-2114.
-
(2001)
Diabetologia
, vol.44
, pp. 2107-2114
-
-
Bonora, E.1
Muggeo, M.2
-
16
-
-
12144251636
-
Postprandial hyperglycemia and diabetes complications. Is it time to treat?
-
Ceriello A. 2005. Postprandial hyperglycemia and diabetes complications. Is it time to treat? Diabetes 54: 1-7.
-
(2005)
Diabetes
, vol.54
, pp. 1-7
-
-
Ceriello, A.1
-
17
-
-
33847039177
-
Role of postprandial hyperglycemia in cardiovascular disease in diabetes
-
Yamagishi SI, Nakamura K, Matsui T, Ueda SI, Imaizumi T. 2007. Role of postprandial hyperglycemia in cardiovascular disease in diabetes. Int J Clin Pract 61: 83-87.
-
(2007)
Int J Clin Pract
, vol.61
, pp. 83-87
-
-
Yamagishi, S.I.1
Nakamura, K.2
Matsui, T.3
Ueda, S.I.4
Imaizumi, T.5
-
18
-
-
2142749660
-
Mechanism of porcine pancreatic alpha-amylase inhibition of amylose and maltopentaose hydrolysis by kidney bean (Phaseolus vulgaris) inhibitor and comparison with that by acarbose
-
Koukiekolo R, Le Berre-Anton V, Desseaux V, Moreau Y, Rouge P, Marchis-Mouren G, Santimone M. 1999. Mechanism of porcine pancreatic alpha-amylase inhibition of amylose and maltopentaose hydrolysis by kidney bean (Phaseolus vulgaris) inhibitor and comparison with that by acarbose. Eur J Biochem 265: 20-26.
-
(1999)
Eur J Biochem
, vol.265
, pp. 20-26
-
-
Koukiekolo, R.1
Le Berre-Anton, V.2
Desseaux, V.3
Moreau, Y.4
Rouge, P.5
Marchis-Mouren, G.6
Santimone, M.7
-
19
-
-
0031818512
-
Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese and diabetic humans
-
Lankisch M, Layer P, Rizza RA, DiMagno EE 1998. Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese and diabetic humans. Pancreas 17: 176-181.
-
(1998)
Pancreas
, vol.17
, pp. 176-181
-
-
Lankisch, M.1
Layer, P.2
Rizza, R.A.3
DiMagno, E.E.4
-
20
-
-
0022559032
-
Effect of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in human
-
Layer P, Zinsmeister AR, DiMagno EP. 1986. Effect of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in human. Gastroenterology 91: 41-48.
-
(1986)
Gastroenterology
, vol.91
, pp. 41-48
-
-
Layer, P.1
Zinsmeister, A.R.2
DiMagno, E.P.3
-
21
-
-
0014004384
-
Diabetes, a new mutation in the mouse
-
Hummel KP, Dickie MM, Coleman DL. 1966. Diabetes, a new mutation in the mouse. Science 153: 1127-1128.
-
(1966)
Science
, vol.153
, pp. 1127-1128
-
-
Hummel, K.P.1
Dickie, M.M.2
Coleman, D.L.3
-
22
-
-
0033956846
-
The db/db mouse, a model for diabetic dyslipidemia: Molecular characterization and effects of Western diet feeding
-
Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. 2000. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49: 22-31.
-
(2000)
Metabolism
, vol.49
, pp. 22-31
-
-
Kobayashi, K.1
Forte, T.M.2
Taniguchi, S.3
Ishida, B.Y.4
Oka, K.5
Chan, L.6
-
23
-
-
0018139377
-
Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice
-
Coleman DL. 1978. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14: 141-148.
-
(1978)
Diabetologia
, vol.14
, pp. 141-148
-
-
Coleman, D.L.1
|